University of California

Eberhard-karls-universitat Tubingen

Weiguo Zhang

Pamela C Ronald

Rory Pruitt

Benjamin Schwessinger

Anna Joe

Andrea Gust

Jian-Hua Mao

Malou Fraiture

Frédéric Brunner

Gary Karpen

The invention described in the application relates to a panel of gene expression markers for patient with a tumor. The invention thus provides methods and compositions, e.g., kits, for evaluating gene expression levels of the markers and methods of using such gene expression levels to evaluate the likelihood of disease progression or response to chemotherapy or radiation therapy. Such information can be used in determining prognosis and treatment options for cancer patients.

Centromere/kinetochore protein genes for cancer diagnosis, prognosis and treatment selection

Provided herein are compounds and methods for increasing disease resistance and/or root length in plants.

Engineering pathogen resistance in plants

The invention relates to a plant having increased resistance to pathogens, wherein the protein SOBIR1 fromor a homologous protein, which is capable of interacting with at least one of the PRR receptor proteins RLP30 or RLP1, and at least one of the PRR receptor proteins RLP30 or RLP1 are overexpressed in comparison with the wild-type plant or are newly synthesized. The pathogens are preferably fungi, in particular from the genus, and bacteria, in particular from the genus. The invention further relates to a method for producing a plant having increased resistance to pathogens.

Plants having increased resistance to pathogens and method for producing said plants

Growing community of inventors

Zurich, Switzerland

Weiguo Zhang